Evidence map›Paper›PMID 36033495›Full record

ArticleFrontiers in oncology2022

Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma.

Long Chen, Zujian Xiong, Hongyu Zhao, Chubei Teng, Hongwei Liu, Qi Huang, Siyi Wanggou, Xuejun Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Long ChenDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Zujian XiongDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Hongyu ZhaoDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Chubei TengDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Hongwei LiuDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Qi HuangDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Siyi WanggouDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Xuejun LiDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: This study aimed to explore the expression pattern of Methods: Using large-scale bioinformatic approach and RNA sequencing (RNA-seq) data from public databases The Cancer Genome Atlas (TCGA), Chinese Glioma Genome Atlas (CGGA), and The Gene Expression Omnibus (GEO)), we investigated the relationship between Results: We found that Conclusion:

Indexed as

bioinformaticsgliomaimmune infiltrationsingle-cell RNA sequencingtumoral heterogeneity

Identifiers

PMID36033495
PMCPMC9414891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.